Syndecan-1 in the Tumor Microenvironment

被引：7
|
作者：
Handra-Luca, Adriana [1 ,2 ]
机构：
[1] Univ Sorbonne Paris Nord, Serv Anat Pathol, Bobigny, France
[2] Univ Sorbonne Paris Nord, APHP GHU Avicenne, Bobigny, France
来源：
TUMOR MICROENVIRONMENT: EXTRACELLULAR MATRIX COMPONENTS - PT B | 2020年 / 1272卷
关键词：
Syndecan-1; Tumor; Stroma; Microenvironment; Pathology; Microscopy; Immunohistochemistry; Fibroblast; Vessels; Inflammatory cells; Extracellular matrix; Adenocarcinoma; Squamous cell carcinoma; Morphotype; Prognosis; STROMAL FIBROBLASTS; PROGNOSTIC VALUE; EXPRESSION; CELLS; CARCINOMAS; MYELOMA;
D O I：
10.1007/978-3-030-48457-6_3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Syndecan-1 along with the other three syndecan proteins is present in the varied components of the tumor microenvironment: fibroblasts, inflammatory tumor immunity-associated cells, vessels, and extracellular matrix. Epithelial and non-epithelial tumors may show stromal syndecans. The main relevance of stromal syndecans as tumor biomarker resides in the relationships to tumor features such as type and differentiation as well as to prognosis.
引用
收藏
页码：39 / 53
页数：15
相关论文
共 50 条
  • [1] Syndecan-1: a dynamic regulator of the myeloma microenvironment
    Ralph D. Sanderson
    Yang Yang
    Clinical & Experimental Metastasis, 2008, 25 : 149 - 159
  • [2] Syndecan-1: a dynamic regulator of the myeloma microenvironment
    Sanderson, Ralph D.
    Yang, Yang
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (02) : 149 - 159
  • [3] Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
    Colleen Chute
    Xinhai Yang
    Kristy Meyer
    Ning Yang
    Keelin O’Neil
    Ildiko Kasza
    Kevin Eliceiri
    Caroline Alexander
    Andreas Friedl
    Breast Cancer Research, 20
  • [4] Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
    Chute, Colleen
    Yang, Xinhai
    Meyer, Kristy
    Yang, Ning
    O'Neil, Keelin
    Kasza, Ildiko
    Eliceiri, Kevin
    Alexander, Caroline
    Friedl, Andreas
    BREAST CANCER RESEARCH, 2018, 20
  • [5] Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: A multifunctional regulator of cell behavior within the tumor microenvironment
    Dhodapkar, MV
    Sanderson, RD
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 35 - 43
  • [6] SUPPRESSION OF TUMOR-CELL GROWTH BY SYNDECAN-1 ECTODOMAIN
    MALI, M
    ANDTFOLK, H
    MIETTINEN, HM
    JALKANEN, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (45) : 27795 - 27798
  • [7] Shed syndecan-1 translocates to the nucleus of tumor and host cells
    Stewart, Mark
    Ramani, Vishnu
    Sanderson, Ralph
    GLYCOBIOLOGY, 2012, 22 (11) : 1604 - 1604
  • [8] Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis
    Andersen, Niels F.
    Kristensen, Ida B.
    Preiss, Birgitte S.
    Christensen, Jacob H.
    Abildgaard, Niels
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) : 211 - 217
  • [9] Syndecan-1 in Liver Diseases
    Regos, Eszter
    Karaszi, Katalin
    Reszegi, Andrea
    Kiss, Andras
    Schaff, Zsuzsa
    Baghy, Kornelia
    Kovalszky, Ilona
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 813 - 819
  • [10] Focus on Molecules: Syndecan-1
    Zhang, Yinghui
    McKown, Robert L.
    Raab, Ronald W.
    Rapraeger, Alan C.
    Laurie, Gordon W.
    EXPERIMENTAL EYE RESEARCH, 2011, 93 (04) : 329 - 330
12345